News, analysis and commentary for FL medical specialists
Learn More
June 21, 2022 | Volume XI | Issue 25
Pharma under the microscope as FTC considers new ways to review acquisitions
Jonathan Gardner reports for Healthcare Dive:

Drugmaker acquisitions of all sizes could receive closer scrutiny in the future if the Federal Trade Commission follows the advice of experts who spoke at a two-day agency meeting on market concentration and anticompetitive conduct.

The experts, mostly economists and other antitrust regulators, warned that some drugmakers have gained unfair market power due to the breadth of their product portfolios, allowing them to negotiate for preferred or even exclusive status on insurers’ coverage lists and thereby squeeze out competitors.
Read More
Buy and Bust: When Private Equity Comes for Rural Hospitals
Sarah Jane Tribble, Kaiser Health News

MEXICO, Mo. — When the new corporate owners of two rural hospitals suddenly announced they would stop admitting patients one Friday in March, Kayla Schudel, a nurse, stood resolute in the nearly empty lobby of Audrain Community Hospital: “You’ll be seen; the ER is open.”

The hospital — with 40 beds and five clinics — typically saw 24 to 50 emergency room cases a day, treating patients from the surrounding 1,000-plus acre farms and tiny no-stoplight towns, she said. She wouldn’t abandon them.

A week later Noble Health had the final word: It locked the doors.

Noble, a three-year-old startup that acquired Audrain and nearby Callaway Community Hospital, offered explanations on social media, including “a technology issue” and a need to “restructure their operations” to keep the hospitals financially viable.

The company should have had plentiful resources to keep them afloat: Noble was launched in late 2019 by Nueterra Capital, a venture capital and private equity firm that has raised millions of dollars to back dozens of health care companies, according to Nueterra’s portfolio and federal filings.
Read More
Learn More
Precision medicine: the rifle vs. shotgun approach to cancer treatment
Hirva Mamdani, MD writes in a KevinMD blog post:

Why does one person respond favorably to lung cancer treatment while another does not?

The answer lies in their DNA.

Just 20 years ago, lung cancer was broadly categorized into two groups: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Relatively recently, the treatment of NSCLC shifted from chemotherapy as a single treatment option to treatment with precision medicine...
Read More
WHO Officials Say Monkeypox Outbreak Is 'Real Risk' To Public Health
WHO Officials Say Monkeypox Outbreak Is 'Real Risk' To Public Health
NBC News

World Health Organization officials say that if the monkeypox outbreak continues, the virus will get stronger in Europe, Australia and North America.

As the U.S. saw 72 cases last month, Dr. Amesh Adalja with the Johns Hopkins Center for Health Security describes the disease's pandemic potential.
Watch the video HERE.
Inside
FloridaHealthIndustry.com
Home Page
Focus
Compliance Update
Best Practices
Healthcare Headlines
Last Word
Advertise
Publisher of Week in Review, Specialty Focus, FHIweekly & Game Changers